speb/financial-data huggingface dataset:
Financial ratios for HLE.DE — quarterly report dated 2024-09-30
Total revenue: 2116258888.8888888
Gross profit: 441037777.7777778
Operating income: 87738888.88888888
Net income: 76370000
Capital expenditures: 204053333.3333333
Operating cash flow: 91805555.55555555
Depreciation & amortization: 169554444.44444445
Net tangible assets: 2700862222.2222223
Owner earnings: 41871111.111111134
Return on net tangible assets (%): 1.5502868219860662
Capex to operating income (%): 232.56885962135124
Buffett classification: The Gruesome
Stock price: 93.99999999999999
P/E ratio: 34.19027277726856
Shares outstanding: 111111112
Book value: 3491722222.2222214
P/B ratio: 2.9912014367949595
Market cap (USD): 10444444527.999998
Debt to equity: 0
Current ratio: 1.5307990008544403
Quick ratio: 1.054868068291311
Effective tax rate (%): 14.756111173122
Interest coverage ratio: 3.420767631259747
COGS to revenue (%): 79.1595546228591
R&D to revenue (%): 8.47864129204944
SG&A to revenue (%): 7.7658005505522585
Free cash flow (dilution-adjusted): -112247777.77777778
Buyback yield (%): 0
Inventory turnover: 1.2342800492173283
Receivables turnover: 1.8598968998674872
Capitalized R&D asset: 179430000
ROCI (R&D-adjusted, %): 3.8087974418485047
FCF margin (%): -5.304066452697186
Rule of 40 score: -5.304066452697186
Financial ratios for HLE.DE — quarterly report dated 2024-12-31
Total revenue: 2176984375
Gross profit: 357689583.3333334
Operating income: 110270833.33333334
Net income: 62842708.333333336
Capital expenditures: 150942708.33333334
Operating cash flow: 359761458.3333334
Depreciation & amortization: 157878125
Net tangible assets: 2587641666.666667
Owner earnings: 69778125
Return on net tangible assets (%): 2.6965914909650675
Capex to operating income (%): 136.883619875307
Buffett classification: The Gruesome
Stock price: 91.20833333333334
P/E ratio: 40.31597145120921
Shares outstanding: 111111112
Book value: 3382605208.333333
P/B ratio: 2.9959923538717237
Market cap (USD): 10134259340.333334
Debt to equity: 0.2953166337213582
Current ratio: 1.4840927773507606
Quick ratio: 1.0575862706915196
Effective tax rate (%): -70.44497810425202
COGS to revenue (%): 83.5694923931949
R&D to revenue (%): 8.504501400781377
SG&A to revenue (%): 5.393690143810365
Free cash flow (dilution-adjusted): 208818750
Buyback yield (%): 0
Retained earnings: 2975802083.3333335
Inventory turnover: 1.562037051943197
Receivables turnover: 2.2200652027734016
Capitalized R&D asset: 305359766.6666667
ROCI (R&D-adjusted, %): 3.238388282698708
Rosenberg metric: -0.464516493587719
FCF margin (%): 9.592110646177696
Revenue growth (%): 2.869473410363049
Rule of 40 score: 12.461584056540746
Financial ratios for HLE.DE — annual report dated 2024-12-31
Total revenue: 8359158333.333334
Gross profit: 1829717708.3333335
Operating income: 342337500
Net income: 386335416.6666667
Capital expenditures: 458779166.6666667
Operating cash flow: 889730208.3333334
Depreciation & amortization: 609855208.3333334
Net tangible assets: 2587641666.666667
Owner earnings: 537411458.3333333
Return on net tangible assets (%): 20.768387882144935
Capex to operating income (%): 134.01370479911395
Buffett classification: The Gruesome
Stock price: 91.20833333333334
P/E ratio: 26.231763651835358
Shares outstanding: 111111112
Book value: 3382605208.333333
P/B ratio: 2.9959923538717237
Market cap (USD): 10134259340.333334
Debt to equity: 0.2953166337213582
Current ratio: 1.4840927773507606
Quick ratio: 1.0575862706915196
Effective tax rate (%): 10.14105800774341
Interest coverage ratio: 5.197924904311517
COGS to revenue (%): 78.11122082665818
R&D to revenue (%): 10.102741603769918
SG&A to revenue (%): 8.023098916457897
Free cash flow (dilution-adjusted): 181025000
Buyback yield (%): 0
Retained earnings: 2975802083.3333335
Inventory turnover: 5.606143782432077
Receivables turnover: 8.524579575958894
Capitalized R&D asset: 1694049714.3369176
ROCI (R&D-adjusted, %): 5.286695688562814
Rosenberg metric: -0.2751580913480943
FCF margin (%): 2.165588840184269
Revenue growth (%): -5.41728516001916
Rule of 40 score: -3.2516963198348914
Financial ratios for HLE.DE — quarterly report dated 2025-03-31
Total revenue: 2170817391.3043475
Gross profit: 497315217.3913043
Operating income: 55072826.086956516
Net income: 26025000
Capital expenditures: 227227173.91304347
Operating cash flow: 158371739.13043478
Depreciation & amortization: 179459782.60869566
Net tangible assets: 2644313043.4782605
Owner earnings: -21742391.304347813
Return on net tangible assets (%): -0.8222321240660839
Capex to operating income (%): 412.593996092131
Buffett classification: The Gruesome
Stock price: 93.34782608695652
P/E ratio: 99.63478154951342
Shares outstanding: 111111112
Book value: 3503925000
P/B ratio: 2.960103529414684
Market cap (USD): 10371980759.304348
Debt to equity: 0
Current ratio: 1.4720111675304586
Quick ratio: 1.0568428517836774
Effective tax rate (%): 34.79835525420037
Interest coverage ratio: 1.874334122521456
COGS to revenue (%): 77.09087740943104
R&D to revenue (%): 11.835053115636669
SG&A to revenue (%): 8.53710684014036
Free cash flow (dilution-adjusted): -68855434.78260869
Buyback yield (%): 0
Inventory turnover: 1.410942621936747
Receivables turnover: 1.9599636497103945
Capitalized R&D asset: 440174207.9710145
ROCI (R&D-adjusted, %): 1.8650050910358433
Rosenberg metric: 0.7541556504909084
FCF margin (%): -3.171866738235247
Revenue growth (%): -0.2832810270240219
Rule of 40 score: -3.4551477652592686
Financial ratios for HLE.DE — quarterly report dated 2025-06-30
Total revenue: 2331120000
Gross profit: 506048235.2941177
Operating income: 90308235.29411764
Net income: 54502352.941176474
Capital expenditures: 168518823.52941176
Operating cash flow: 367569411.7647059
Depreciation & amortization: 174088235.29411766
Net tangible assets: 2680505882.352941
Owner earnings: 60071764.70588237
Return on net tangible assets (%): 2.241060730415243
Capex to operating income (%): 186.60404887835128
Buffett classification: The Gruesome
Stock price: 100.87058823529411
P/E ratio: 51.00500637849678
Shares outstanding: 111111112
Book value: 3622508235.294118
P/B ratio: 3.093945547927143
Market cap (USD): 11207843226.917646
Debt to equity: 0.30468391741568723
Current ratio: 1.467152592529658
Quick ratio: 1.0558752791127866
Effective tax rate (%): 38.37200021284521
Interest coverage ratio: 1.5803755249938236
COGS to revenue (%): 78.29157607653377
R&D to revenue (%): 9.136935943944138
SG&A to revenue (%): 8.588499746650436
Free cash flow (dilution-adjusted): 199050588.23529413
Buyback yield (%): 0
Retained earnings: 3309131764.7058825
Inventory turnover: 1.4306701686949657
Receivables turnover: 1.9791107120276714
Capitalized R&D asset: 446224343.35038364
ROCI (R&D-adjusted, %): 1.443850642755564
Rosenberg metric: 0.03399154046550365
FCF margin (%): 8.53883919469157
Revenue growth (%): 7.384435436060967
Rule of 40 score: 15.923274630752537
Financial ratios for HLE.DE — quarterly report dated 2025-09-30
Total revenue: 2230395294.117647
Gross profit: 472172941.1764706
Operating income: 75382352.94117647
Net income: 44456470.5882353
Capital expenditures: 159225882.3529412
Operating cash flow: 94644705.88235295
Depreciation & amortization: 167851764.70588237
Net tangible assets: 2688821176.470588
Owner earnings: 53082352.941176474
Return on net tangible assets (%): 1.9741868074266529
Capex to operating income (%): 211.22434646898168
Buffett classification: The Gruesome
Stock price: 95.23529411764706
P/E ratio: 56.337618152857324
Shares outstanding: 111111112
Book value: 3670474117.6470594
P/B ratio: 2.8829244102781395
Market cap (USD): 10581699431.058823
Debt to equity: 0
Current ratio: 1.4690854168372895
Quick ratio: 1.0417513432386671
Effective tax rate (%): 37.200026590440736
Interest coverage ratio: 3.2697999591753417
COGS to revenue (%): 78.83007812912086
R&D to revenue (%): 8.983002749182946
SG&A to revenue (%): 8.071109526351435
Free cash flow (dilution-adjusted): -64581176.47058824
Buyback yield (%): 0
Inventory turnover: 1.3321872902424696
Receivables turnover: 1.8512269833814572
Capitalized R&D asset: 427844480.3069054
ROCI (R&D-adjusted, %): 0.8931012502310671
Rosenberg metric: -0.15904421024723295
FCF margin (%): -2.895503619511392
Revenue growth (%): -4.3208717647462525
Rule of 40 score: -7.216375384257645
Financial ratios for HLE.DE — quarterly report dated 2025-12-31
Total revenue: 2338451764.7058825
Gross profit: 499692941.1764706
Operating income: 126949411.76470588
Net income: -18063529.411764707
Capital expenditures: 151472941.17647058
Operating cash flow: 439144705.88235295
Depreciation & amortization: 176203529.4117647
Net tangible assets: 2687401176.470588
Owner earnings: 6667058.823529422
Capex to operating income (%): 119.31756049190506
Buffett classification: The Gruesome
Stock price: 96.88235294117646
P/E ratio: 100.67972649444748
Shares outstanding: 111111112
Book value: 3680276470.588235
P/B ratio: 2.9249720923140368
Market cap (USD): 10764705968.470587
Debt to equity: 0.2888568154246724
Current ratio: 1.4383316562087594
Quick ratio: 1.0219245474621337
Effective tax rate (%): 117.89644239287547
COGS to revenue (%): 78.63146254636048
R&D to revenue (%): 9.139933711797248
SG&A to revenue (%): 8.157131616494373
Free cash flow (dilution-adjusted): 287671764.7058824
Buyback yield (%): 0
Retained earnings: 3330484705.882353
Inventory turnover: 1.3840079908685907
Receivables turnover: 2.2914315885096643
Capitalized R&D asset: 418259447.0588236
ROCI (R&D-adjusted, %): 2.2521436804421335
Rosenberg metric: 0.13735518458277307
FCF margin (%): 12.301804512186042
Revenue growth (%): 4.844722855774449
Rule of 40 score: 17.14652736796049
Financial ratios for HLE.DE — annual report dated 2025-12-31
Total revenue: 9249557647.058825
Gross profit: 2016184705.882353
Operating income: 350038823.5294118
Net income: 109063529.41176471
Capital expenditures: 394528235.2941176
Operating cash flow: 1072772941.1764706
Depreciation & amortization: 712382352.9411765
Net tangible assets: 2687401176.470588
Owner earnings: 426917647.05882365
Return on net tangible assets (%): 15.88589194634134
Capex to operating income (%): 112.70985067202628
Buffett classification: The Gruesome
Stock price: 96.88235294117646
P/E ratio: 98.70124345443561
Shares outstanding: 111111112
Book value: 3680276470.588235
P/B ratio: 2.9249720923140368
Market cap (USD): 10764705968.470587
Debt to equity: 0.2888568154246724
Current ratio: 1.4383316562087594
Quick ratio: 1.0219245474621337
Effective tax rate (%): 64.04787205162611
Interest coverage ratio: 5.288159391440352
COGS to revenue (%): 78.20236617992796
R&D to revenue (%): 9.785943340501877
SG&A to revenue (%): 8.341638976948214
Free cash flow (dilution-adjusted): 347615294.11764705
Buyback yield (%): 0
Retained earnings: 3330484705.882353
Inventory turnover: 5.444458415870517
Receivables turnover: 9.063573126502984
Capitalized R&D asset: 1768921728.9215686
ROCI (R&D-adjusted, %): 5.155590634318051
Rosenberg metric: 0.22080056547858307
FCF margin (%): 3.758182903245993
Revenue growth (%): 10.651781892620654
Rule of 40 score: 14.409964795866648
Financial ratios for HLIT — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 507000
Buffett classification: The Gruesome
Stock price: 11.76
Shares outstanding: 108496436
Market cap (USD): 1275918087.36
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HLIT — annual report dated 2022-12-31
Total revenue: 624957000
Gross profit: 315884000
Operating income: 48860000
Net income: 28182000
Capital expenditures: 9250000
Operating cash flow: 5476000
Depreciation & amortization: 12260000
Net tangible assets: 86767000
Owner earnings: 31192000
Return on net tangible assets (%): 35.949151174985886
Capex to operating income (%): 18.9316414244781
Buffett classification: The Great
Stock price: 13.1
P/E ratio: 50.43301794052941
Shares outstanding: 108496436
Book value: 324506000
P/B ratio: 4.379898404343834
Market cap (USD): 1421303311.6
Debt to equity: 0.4954638743197352
Current ratio: 1.0721174147395613
Quick ratio: 0.6965833726620134
Effective tax rate (%): 36.64830841856806
Interest coverage ratio: 9.694444444444445
COGS to revenue (%): 49.455082509676664
R&D to revenue (%): 19.250444430576824
SG&A to revenue (%): 23.476335171859823
Free cash flow (dilution-adjusted): -28986000
Buyback yield (%): 0.36114740309875465
Retained earnings: -2046569000
Inventory turnover: 2.5553993832111055
Receivables turnover: 5.481598105429348
Capitalized R&D asset: 120307000
ROCI (R&D-adjusted, %): 25.39378354218601
FCF margin (%): -4.638079099842069
Rule of 40 score: -4.638079099842069
Financial ratios for HLIT — annual report dated 2023-12-31
Total revenue: 388482000
Gross profit: 178121000
Operating income: 30139000
Net income: 83994000
Capital expenditures: 8475000
Operating cash flow: 7059000
Depreciation & amortization: 12255000
Net tangible assets: 197724000
Owner earnings: 87774000
Return on net tangible assets (%): 44.392183043029675
Capex to operating income (%): 28.119712001061746
Buffett classification: The Good
Stock price: 13.04
P/E ratio: 16.843983206419505
Shares outstanding: 108496436
Book value: 436874000
P/B ratio: 3.2384475282117955
Market cap (USD): 1414793525.4399998
Debt to equity: 0.35719910088492335
Current ratio: 1.214167712945219
Quick ratio: 0.9058569572017005
Effective tax rate (%): -217.24905728137904
Interest coverage ratio: 14.868771583621115
COGS to revenue (%): 54.14948440339579
R&D to revenue (%): 17.943688510664586
SG&A to revenue (%): 20.14868127738222
Free cash flow (dilution-adjusted): -28745000
Buyback yield (%): 0
Retained earnings: -1962575000
Inventory turnover: 2.5048343692696053
Receivables turnover: 2.6553249078966257
Capitalized R&D asset: 150313690
ROCI (R&D-adjusted, %): 5.650397009700491
Rosenberg metric: -1.1450954641043332
FCF margin (%): -7.399313224293532
Revenue growth (%): -37.83860329590676
Rule of 40 score: -45.23791652020029
Financial ratios for HLIT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.57
Shares outstanding: 108496436
Market cap (USD): 1580793072.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HLIT — annual report dated 2024-12-31
Total revenue: 488200000
Gross profit: 240107000
Operating income: 88364000
Net income: 39217000
Capital expenditures: 9186000
Operating cash flow: 61917000
Depreciation & amortization: 12139000
Net tangible assets: 404485000
Owner earnings: 42170000
Return on net tangible assets (%): 10.425602927179005
Capex to operating income (%): 10.395636231949663
Buffett classification: The Great
Stock price: 13.23
P/E ratio: 36.601673975061836
Shares outstanding: 108496436
Book value: 465258000
P/B ratio: 3.085186817378745
Market cap (USD): 1435407848.28
Debt to equity: 0.28947379733395234
Current ratio: 2.939105381130937
Quick ratio: 2.7151646271381247
Effective tax rate (%): 29.101431447103554
Interest coverage ratio: 13.668058778035576
COGS to revenue (%): 50.81790249897583
R&D to revenue (%): 14.865628840639083
SG&A to revenue (%): 16.216509627201965
Free cash flow (dilution-adjusted): 24658000
Buyback yield (%): 2.093272656688083
Retained earnings: -1953495000
Inventory turnover: 5.761565257779842
Receivables turnover: 3.372501882439088
Capitalized R&D asset: 158979670
ROCI (R&D-adjusted, %): 9.618458663585825
Rosenberg metric: 0.8892236185229816
FCF margin (%): 5.050798852929128
Revenue growth (%): 25.668628147507476
Rule of 40 score: 30.719427000436603
Financial ratios for HLIT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.23
Shares outstanding: 108496436
Market cap (USD): 1435407848.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for HLIT — quarterly report dated 2025-03-31
Total revenue: 84878000
Gross profit: 46480000
Operating income: 7036000
Net income: 5940000
Capital expenditures: 1872000
Operating cash flow: 83605000
Depreciation & amortization: 2720000
Net tangible assets: 207930000
Owner earnings: 6788000
Return on net tangible assets (%): 3.2645601885249844
Capex to operating income (%): 26.606026151222284
Buffett classification: The Good
Stock price: 9.59
P/E ratio: 43.79128035521885
Shares outstanding: 108496436
Book value: 446130000
P/B ratio: 2.3322368395759088
Market cap (USD): 1040480821.24
Debt to equity: 0.33301952345728825
Current ratio: 2.0620381186410928
Quick ratio: 1.6864502696388473
Effective tax rate (%): 53.58542319749217
Interest coverage ratio: 5.366895499618612
COGS to revenue (%): 45.239048987959194
R&D to revenue (%): 23.16736963641933
SG&A to revenue (%): 23.304036381630105
Free cash flow (dilution-adjusted): 73268000
Buyback yield (%): 3.4675314780913125
Retained earnings: -1983872000
Inventory turnover: 0.6187736685198614
Receivables turnover: 0.8134517888118992
Capitalized R&D asset: 19664000
ROCI (R&D-adjusted, %): 3.206880285348458
FCF margin (%): 86.32154386295625
Rule of 40 score: 86.32154386295625
Financial ratios for HLIT — quarterly report dated 2025-06-30
Total revenue: 138027000
Gross profit: 73793000
Operating income: 6157000
Net income: 2871000
Capital expenditures: 3800000
Operating cash flow: -11697000
Depreciation & amortization: 2672000
Net tangible assets: 204684000
Owner earnings: 1743000
Return on net tangible assets (%): 0.8515565456997127
Capex to operating income (%): 61.71836933571545
Buffett classification: The Good
Stock price: 9.47
P/E ratio: 116.6111961094087
Shares outstanding: 108496436
Book value: 446402000
P/B ratio: 2.301650191800216
Market cap (USD): 1027461248.9200001
Debt to equity: 0.338163807509823
Current ratio: 1.990935433107445
Quick ratio: 1.5778443635350068
Effective tax rate (%): 3.5282258064516134
Interest coverage ratio: 4.913806863527534
COGS to revenue (%): 46.537271693219445
R&D to revenue (%): 21.330609228629182
SG&A to revenue (%): 27.671397625102333
Free cash flow (dilution-adjusted): -23194000
Buyback yield (%): 1.3648203292085281
Retained earnings: -1995193000
Inventory turnover: 0.9029491973347578
Receivables turnover: 1.1050293015659525
Capitalized R&D asset: 42616880
ROCI (R&D-adjusted, %): 2.941520426330636
Rosenberg metric: 1.3889849471114728
FCF margin (%): -16.803958645772205
Revenue growth (%): 62.618110700063625
Rule of 40 score: 45.81415205429142
Financial ratios for HLIT — quarterly report dated 2025-09-30
Total revenue: 142382000
Gross profit: 77129000
Operating income: 10906000
Net income: 2694000
Capital expenditures: 2732000
Operating cash flow: 23770000
Depreciation & amortization: 2823000
Net tangible assets: 201244000
Owner earnings: 2785000
Return on net tangible assets (%): 1.3838921905746258
Capex to operating income (%): 25.050430955437374
Buffett classification: The Good
Stock price: 10.18
P/E ratio: 96.00119239287265
Shares outstanding: 108496436
Book value: 443011000
P/B ratio: 2.4931519047608295
Market cap (USD): 1104493718.48
Debt to equity: 0.33083151434163033
Current ratio: 2.0816475920102864
Quick ratio: 1.644963144963145
Effective tax rate (%): 69.20438957475994
Interest coverage ratio: 9.21114864864865
COGS to revenue (%): 45.8295290134989
R&D to revenue (%): 20.85867595623042
SG&A to revenue (%): 25.652118947619783
Free cash flow (dilution-adjusted): 13714000
Buyback yield (%): 1.4173914924155793
Retained earnings: -2008215000
Inventory turnover: 0.9511544516354732
Receivables turnover: 1.30760047020792
Capitalized R&D asset: 55914260
ROCI (R&D-adjusted, %): 2.1807892213825975
Rosenberg metric: 0.11330751986957407
FCF margin (%): 9.631835484822519
Revenue growth (%): 3.1551797836655147
Rule of 40 score: 12.787015268488034
Financial ratios for HLIT — annual report dated 2025-12-31
Total revenue: 360523000
Gross profit: 174745000
Operating income: 17032000
Net income: -43310000
Capital expenditures: 11080000
Operating cash flow: 107966000
Depreciation & amortization: 11082000
Net tangible assets: 322346000
Owner earnings: -43308000
Return on net tangible assets (%): -13.435252802888822
Capex to operating income (%): 65.05401596993894
Buffett classification: The Good
Stock price: 9.89
Shares outstanding: 108496436
Book value: 383246000
P/B ratio: 2.799845926741571
Market cap (USD): 1073029752.0400001
Debt to equity: 0.3475078670097013
Current ratio: 2.49747913593469
Quick ratio: 2.2557995028997513
Effective tax rate (%): 86.2769439115224
Interest coverage ratio: 4.483285075019742
COGS to revenue (%): 51.530138160394756
R&D to revenue (%): 21.171742163468075
SG&A to revenue (%): 22.573871847288522
Free cash flow (dilution-adjusted): 65004000
Buyback yield (%): 7.364847046389637
Retained earnings: -2076406000
Inventory turnover: 3.883319397993311
Receivables turnover: 4.101793068923931
Capitalized R&D asset: 147957220
ROCI (R&D-adjusted, %): 3.065206453212974
Rosenberg metric: -0.9006255683853722
FCF margin (%): 18.0304723970454
Revenue growth (%): -26.152601392871773
Rule of 40 score: -8.122128995826372
Financial ratios for HLIT — quarterly report dated 2025-12-31
Total revenue: -53021000
Gross profit: -54751000
Operating income: -10158000
Net income: -54815000
Capital expenditures: 2676000
Operating cash flow: 12288000
Depreciation & amortization: 2867000
Net tangible assets: 322346000
Owner earnings: -54624000
Return on net tangible assets (%): -16.94576635044331
Buffett classification: The Gruesome
Stock price: 9.89
Shares outstanding: 108496436
Book value: 383246000
P/B ratio: 2.799845926741571
Market cap (USD): 1073029752.0400001
Debt to equity: 0.3475078670097013
Current ratio: 2.49747913593469
Quick ratio: 2.2557995028997513
Free cash flow (dilution-adjusted): 1216000
Buyback yield (%): 1.236685187411777
Retained earnings: -2076406000
Inventory turnover: 0.03616220735785953
Receivables turnover: -0.6032379912166929
Capitalized R&D asset: 15453190
ROCI (R&D-adjusted, %): -7.334552153720651
Rosenberg metric: -4.440553553991717
Revenue growth (%): -137.23855543537806
Rule of 40 score: -137.23855543537806
Financial ratios for ID8.AX — annual report dated 2021-06-30
Total revenue: 1025712.0300751879
Gross profit: 1025712.0300751879
Operating income: -5441298.496240601
Net income: -4380032.330827068
Capital expenditures: 33936.84210526315
Depreciation & amortization: 302265.41353383457
Net tangible assets: 3444836.842105263
Owner earnings: -4111703.7593984962
Return on net tangible assets (%): -119.35844708644277
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 924152370
Book value: 3403927.067669173
P/B ratio: 12.247937024529165
Market cap (USD): 41691084.36090225
Debt to equity: 0.007297851243466469
Current ratio: 4.047350027901786
Quick ratio: 4.047350027901786
Interest coverage ratio: -154.777402314092
COGS to revenue (%): 0
R&D to revenue (%): 146.50332759857997
SG&A to revenue (%): 376.39739715011837
Free cash flow (dilution-adjusted): -3612593.9849624056
Buyback yield (%): 0.6157083526532896
Retained earnings: -19860737.59398496
Receivables turnover: 3.5782122538694985
Capitalized R&D asset: 1502702.2556390977
ROCI (R&D-adjusted, %): -90.4795675392062
FCF margin (%): -352.20353072173594
Rule of 40 score: -352.20353072173594
Financial ratios for ID8.AX — annual report dated 2022-06-30
Total revenue: 1005260
Gross profit: 1005260
Operating income: -5396044.137931035
Net income: -3333766.896551724
Capital expenditures: 43466.206896551725
Depreciation & amortization: 68451.03448275862
Net tangible assets: 5125926.8965517245
Owner earnings: -3308782.0689655175
Return on net tangible assets (%): -64.54992698376905
Buffett classification: The Gruesome
Stock price: 0.027586206896551727
Shares outstanding: 924152370
Book value: 5125926.8965517245
P/B ratio: 4.973511912530134
Market cap (USD): 25493858.482758623
Debt to equity: 0
Current ratio: 5.0667016920432255
Quick ratio: 5.0667016920432255
Interest coverage ratio: -116780.05970149253
COGS to revenue (%): 0
R&D to revenue (%): 187.74069086261437
SG&A to revenue (%): 363.3917319039782
Free cash flow (dilution-adjusted): -4193124.1379310344
Buyback yield (%): 0.8867937004803655
Retained earnings: -20277513.79310345
Receivables turnover: 2.3049494773794654
Capitalized R&D asset: 2894092.5802437128
ROCI (R&D-adjusted, %): -57.83972043029543
Rosenberg metric: -0.013610167948067454
FCF margin (%): -417.1183711607976
Revenue growth (%): -1.993934893567419
Rule of 40 score: -419.11230605436504
Financial ratios for ID8.AX — annual report dated 2023-06-30
Total revenue: 902690.7284768212
Gross profit: 902690.7284768212
Operating income: -4676453.642384106
Net income: -3971856.953642384
Capital expenditures: 0
Depreciation & amortization: 9188.741721854305
Net tangible assets: 1539672.847682119
Owner earnings: -3962668.21192053
Return on net tangible assets (%): -257.3707926255944
Buffett classification: The Gruesome
Stock price: 0.013245033112582781
Shares outstanding: 924152370
Book value: 1539672.847682119
P/B ratio: 7.950019226583786
Market cap (USD): 12240428.741721854
Debt to equity: 0.42152241854079264
Current ratio: 1.4010677714712163
Quick ratio: 1.4010677714712163
Interest coverage ratio: -134.00852089421946
COGS to revenue (%): 0
R&D to revenue (%): 251.3075331074206
SG&A to revenue (%): 298.3267831347487
Free cash flow (dilution-adjusted): -3446176.158940397
Buyback yield (%): 0.1953628058109076
Retained earnings: -23443641.721854303
Receivables turnover: 20.43695274079405
Capitalized R&D asset: 4028900.5318923024
ROCI (R&D-adjusted, %): -77.11302201960899
Rosenberg metric: -0.054347610889664444
FCF margin (%): -381.76709367065206
Revenue growth (%): -10.203258015158147
Rule of 40 score: -391.9703516858102
Financial ratios for ID8.AX — annual report dated 2024-06-30
Total revenue: 498861.3333333333
Gross profit: 498861.3333333333
Operating income: -3464832.6666666665
Net income: -2362344
Capital expenditures: 0
Depreciation & amortization: 8626.666666666666
Net tangible assets: 786492.6666666666
Owner earnings: -2353717.3333333335
Return on net tangible assets (%): -299.26754985636654
Buffett classification: The Gruesome
Stock price: 0.006666666666666667
Shares outstanding: 924152370
Book value: 631133.3333333335
P/B ratio: 9.761829196155064
Market cap (USD): 6161015.800000001
Debt to equity: 0.9388560261962605
Current ratio: 0.9279484671743861
Quick ratio: 0.9279484671743861
Interest coverage ratio: -69.12982003431718
COGS to revenue (%): 0
R&D to revenue (%): 306.1806086394082
SG&A to revenue (%): 414.83217781293934
Free cash flow (dilution-adjusted): -2485816
Buyback yield (%): 0.5926295465757448
Retained earnings: -25909610
Receivables turnover: 2.221077158249358
Capitalized R&D asset: 3670134.716312705
ROCI (R&D-adjusted, %): -89.08595019169348
Rosenberg metric: -0.1780137051352414
FCF margin (%): -498.29799062398104
Revenue growth (%): -44.736185096849276
Rule of 40 score: -543.0341757208303
Financial ratios for IK1.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.511363636363633
Shares outstanding: 496128817
Market cap (USD): 13153051477.965908
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IK1.DE — annual report dated 2022-12-31
Total revenue: 2240461000
Gross profit: 756188000
Operating income: -1511756000
Net income: -1377987000
Capital expenditures: 32402000
Operating cash flow: -625519000
Depreciation & amortization: 169252000
Net tangible assets: -340614000
Owner earnings: -1241137000
Buffett classification: The Gruesome
Stock price: 14.258064516129032
Shares outstanding: 496128817
Book value: 1322693000
P/B ratio: 5.348056337409191
Market cap (USD): 7073836681.096774
Debt to equity: 1.0015082865033684
Current ratio: 1.672613656146983
Quick ratio: 1.672613656146983
Interest coverage ratio: -570.2587702753677
COGS to revenue (%): 66.24855331112659
R&D to revenue (%): 14.204532013723961
SG&A to revenue (%): 87.02213517664444
Free cash flow (dilution-adjusted): -1307963000
Buyback yield (%): 0.3607518967492386
Retained earnings: -5131801000
Receivables turnover: 10.609248034851785
Capitalized R&D asset: 318247000
ROCI (R&D-adjusted, %): -41.761425287917746
FCF margin (%): -58.37919071119738
Rule of 40 score: -58.37919071119738
Financial ratios for IK1.DE — annual report dated 2023-12-31
Total revenue: 3665393000
Gross profit: 1373218000
Operating income: -789225000
Net income: -802142000
Capital expenditures: 20902000
Operating cash flow: -1751000
Depreciation & amortization: 201920000
Net tangible assets: -736687000
Owner earnings: -621124000
Buffett classification: The Gruesome
Stock price: 14.258064516129032
Shares outstanding: 496128817
Book value: 840306000
P/B ratio: 8.418167525992644
Market cap (USD): 7073836681.096774
Debt to equity: 1.6018997841262588
Current ratio: 1.3366935119577703
Quick ratio: 1.3366935119577703
Interest coverage ratio: -294.5968645016797
COGS to revenue (%): 62.535586224996884
R&D to revenue (%): 9.689438485859498
SG&A to revenue (%): 49.306772834454584
Free cash flow (dilution-adjusted): -513599000
Buyback yield (%): 1.1316206976323444
Retained earnings: -5933943000
Receivables turnover: 10.493268137952358
Capitalized R&D asset: 568381490
ROCI (R&D-adjusted, %): -22.22062890456812
Rosenberg metric: 1.938839957642963
FCF margin (%): -14.012112752984468
Revenue growth (%): 63.59994661812903
Rule of 40 score: 49.58783386514456
Financial ratios for IK1.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.258064516129032
Shares outstanding: 496128817
Market cap (USD): 7073836681.096774
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IK1.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 14.258064516129032
Shares outstanding: 496128817
Market cap (USD): 7073836681.096774
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IK1.DE — annual report dated 2024-12-31
Total revenue: 4767699000
Gross profit: 1817138000
Operating income: -608999000
Net income: -507285000
Capital expenditures: 10176000
Operating cash flow: 417767000
Depreciation & amortization: 270854000
Net tangible assets: -1477611000
Owner earnings: -246607000
Buffett classification: The Gruesome
Stock price: 14.258064516129032
Shares outstanding: 496128817
Book value: 1010626000
P/B ratio: 6.999460414729855
Market cap (USD): 7073836681.096774
Debt to equity: 1.32104458028984
Current ratio: 0.9267488463683489
Quick ratio: 0.9267488463683489
Interest coverage ratio: -205.81243663399798
COGS to revenue (%): 61.886478152249126
R&D to revenue (%): 8.329259040891634
SG&A to revenue (%): 42.55769921716954
Free cash flow (dilution-adjusted): -84457000
Buyback yield (%): 2.134117690381757
Retained earnings: -6441228000
Receivables turnover: 82.43052265772229
Capitalized R&D asset: 740090030
ROCI (R&D-adjusted, %): -16.881974093493984
Rosenberg metric: 1.2499296083974367
FCF margin (%): -1.7714415276635542
Revenue growth (%): 30.073337292890557
Rule of 40 score: 28.301895765227002
Financial ratios for IK1.DE — quarterly report dated 2025-03-31
Total revenue: 1408806000
Gross profit: 565003000
Operating income: -46331000
Net income: -33864000
Capital expenditures: 2647000
Operating cash flow: -119016000
Depreciation & amortization: 70116000
Net tangible assets: -1586726000
Owner earnings: 33605000
Buffett classification: The Gruesome
Stock price: 14.258064516129032
Shares outstanding: 496128817
Book value: 872915000
P/B ratio: 8.103694725255922
Market cap (USD): 7073836681.096774
Debt to equity: 2.198317132825075
Current ratio: 1.2014366794251414
Quick ratio: 1.2014366794251414
Interest coverage ratio: -9.09521005104044
COGS to revenue (%): 59.894903911539274
R&D to revenue (%): 7.3296110323209875
SG&A to revenue (%): 36.06415645589244
Free cash flow (dilution-adjusted): -233386000
Buyback yield (%): 3.0619310250518468
Retained earnings: -6475092000
Receivables turnover: 9.549479078405987
Capitalized R&D asset: 103260000
ROCI (R&D-adjusted, %): 0.721396064354849
FCF margin (%): -16.566227003576078
Rule of 40 score: -16.566227003576078
Financial ratios for IK1.DE — quarterly report dated 2025-06-30
Total revenue: 1512507000
Gross profit: 657948000
Operating income: 150644000
Net income: 157936000
Capital expenditures: 4316000
Operating cash flow: 173921000
Depreciation & amortization: 65299000
Net tangible assets: -1425484000
Owner earnings: 218919000
Return on net tangible assets (%): -15.357520673679955
Capex to operating income (%): 2.865032792544011
Buffett classification: The Great
Stock price: 14.258064516129032
P/E ratio: 57.013965125868644
Shares outstanding: 496128817
Book value: 1009628000
P/B ratio: 7.006379261566414
Market cap (USD): 7073836681.096774
Debt to equity: 1.8917294290570388
Current ratio: 1.3387995830813764
Quick ratio: 1.3387995830813764
Effective tax rate (%): 6.938681827009657
Interest coverage ratio: 12.94192439862543
COGS to revenue (%): 56.49950710971916
R&D to revenue (%): 7.168032941335148
SG&A to revenue (%): 26.372572159996615
Free cash flow (dilution-adjusted): 55133000
Buyback yield (%): 1.8094423969674474
Retained earnings: -6317156000
Receivables turnover: 11.07471462148448
Capitalized R&D asset: 177601200
ROCI (R&D-adjusted, %): 5.682306317855739
Rosenberg metric: 0.9001065272128608
FCF margin (%): 3.645140154723251
Revenue growth (%): 7.360914135800104
Rule of 40 score: 11.006054290523355
Financial ratios for IK1.DE — quarterly report dated 2025-09-30
Total revenue: 1144019000
Gross profit: 359940000
Operating income: -271890000
Net income: -256788000
Capital expenditures: 4433000
Operating cash flow: 287477000
Depreciation & amortization: 66071000
Net tangible assets: -1683871000
Owner earnings: -195150000
Buffett classification: The Gruesome
Stock price: 14.258064516129032
Shares outstanding: 496128817
Book value: 732286000
P/B ratio: 9.659937075264
Market cap (USD): 7073836681.096774
Debt to equity: 2.603615254149335
Current ratio: 1.0949692962801998
Quick ratio: 1.0949692962801998
COGS to revenue (%): 68.53723583262166
R&D to revenue (%): 10.024309036825438
SG&A to revenue (%): 45.20466880357756
Free cash flow (dilution-adjusted): 175444000
Buyback yield (%): 1.4538079494373486
Retained earnings: -6573944000
Receivables turnover: 9.417964633825079
Capitalized R&D asset: 221395190
ROCI (R&D-adjusted, %): -8.666335109873007
Rosenberg metric: -2.7487202191538227
FCF margin (%): 15.33575928371819
Revenue growth (%): -24.362730222075005
Rule of 40 score: -9.026970938356815
Financial ratios for IK1.DE — quarterly report dated 2025-12-31
Total revenue: 1989193000
Gross profit: 914687000
Operating income: 151760000
Net income: 136426000
Capital expenditures: 3956000
Operating cash flow: 320473000
Depreciation & amortization: 74002000
Net tangible assets: -1855387000
Owner earnings: 206472000
Return on net tangible assets (%): -11.128244403997657
Capex to operating income (%): 2.606747496046389
Buffett classification: The Great
Stock price: 14.258064516129032
P/E ratio: 1906.6945232066776
Shares outstanding: 496128817
Book value: 631461000
P/B ratio: 11.20233344750788
Market cap (USD): 7073836681.096774
Debt to equity: 2.9927834023003794
Current ratio: 1.0339156841668133
Quick ratio: 1.0339156841668133
Effective tax rate (%): 6.902907668763817
COGS to revenue (%): 54.017181842083694
R&D to revenue (%): 6.714029257090689
SG&A to revenue (%): 31.639564386160618
Free cash flow (dilution-adjusted): 171891000
Buyback yield (%): 5.398117276589355
Retained earnings: -6437518000
Receivables turnover: 18.841158585676805
Capitalized R&D asset: 246168210
ROCI (R&D-adjusted, %): 5.50825864642726
Rosenberg metric: 4.837347401464946
FCF margin (%): 8.641242956314445
Revenue growth (%): 73.87761916541596
Rule of 40 score: 82.51886212173041
Financial ratios for IK1.DE — annual report dated 2025-12-31
Total revenue: 6054525000
Gross profit: 2497578000
Operating income: -15817000
Net income: 3710000
Capital expenditures: 15352000
Operating cash flow: 662855000
Depreciation & amortization: 275488000
Net tangible assets: -1855387000
Owner earnings: 263846000
Return on net tangible assets (%): -14.22053727874562
Buffett classification: The Gruesome
Stock price: 14.258064516129032
P/E ratio: 1906.6945232066776
Shares outstanding: 496128817
Book value: 631461000
P/B ratio: 11.20233344750788
Market cap (USD): 7073836681.096774
Debt to equity: 2.9927834023003794
Current ratio: 1.0339156841668133
Quick ratio: 1.0339156841668133
Effective tax rate (%): 60.94396121488664
COGS to revenue (%): 58.748572348780456
R&D to revenue (%): 7.596169806879978
SG&A to revenue (%): 33.91650046865774
Free cash flow (dilution-adjusted): 169082000
Buyback yield (%): 11.723298648045997
Retained earnings: -6437518000
Receivables turnover: 57.34700739744452
Capitalized R&D asset: 843179860
ROCI (R&D-adjusted, %): 1.1063814378601071
Rosenberg metric: 1.7134626328963471
FCF margin (%): 2.792655080291187
Revenue growth (%): 26.990504224364837
Rule of 40 score: 29.783159304656024
Financial ratios for JRS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.67
Shares outstanding: 28892471
Market cap (USD): 250497723.57
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JRS — annual report dated 2022-12-31
Total revenue: -122864541
Net income: -123163551
Capital expenditures: 0
Operating cash flow: 62702995
Net tangible assets: 234497086
Owner earnings: -123163551
Return on net tangible assets (%): -52.522422815949184
Buffett classification: The Gruesome
Stock price: 5.58
Shares outstanding: 28892471
Book value: 234497086
P/B ratio: 0.6875138234340362
Market cap (USD): 161219988.18
Debt to equity: 0.4452080909866829
Free cash flow (dilution-adjusted): 62702995
Buyback yield (%): 0
Retained earnings: -10312196
Receivables turnover: -64.03530567571794
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JRS — annual report dated 2023-12-31
Total revenue: 40978642
Net income: 40697413
Capital expenditures: 0
Operating cash flow: 24560426
Net tangible assets: 255547619
Owner earnings: 40697413
Return on net tangible assets (%): 15.925569238037001
Buffett classification: The Gruesome
Stock price: 6.33
P/E ratio: 4.493881255548111
Shares outstanding: 28892471
Book value: 255547619
P/B ratio: 0.7156761708274809
Market cap (USD): 182889341.43
Debt to equity: 0.3854428086062504
COGS to revenue (%): 0
SG&A to revenue (%): 0.6738900718086266
Free cash flow (dilution-adjusted): 24560426
Buyback yield (%): 0
Retained earnings: 23761071
Receivables turnover: 20.24545437927445
Capitalized R&D asset: 0
FCF margin (%): 59.93469964182805
Rule of 40 score: 59.93469964182805
Financial ratios for JRS — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 261204887
Buffett classification: The Gruesome
Stock price: 7.58
Shares outstanding: 28892471
Book value: 261204887
P/B ratio: 0.8384411666080351
Market cap (USD): 219004930.18
Debt to equity: 0.4472241248686898
Buyback yield (%): 0
Retained earnings: 42057513
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JRS — annual report dated 2024-12-31
Total revenue: 25524055
Net income: 25304148
Capital expenditures: 0
Operating cash flow: 2300745
Net tangible assets: 261204887
Owner earnings: 25304148
Return on net tangible assets (%): 9.687471123003913
Buffett classification: The Gruesome
Stock price: 7.58
P/E ratio: 8.654902357510712
Shares outstanding: 28892471
Book value: 261204887
P/B ratio: 0.8384411666080351
Market cap (USD): 219004930.18
Debt to equity: 0.4472241248686898
COGS to revenue (%): 0
SG&A to revenue (%): 0.8456571653681204
Free cash flow (dilution-adjusted): 2300745
Buyback yield (%): 0
Retained earnings: 42057513
Receivables turnover: 16.08682923631844
Capitalized R&D asset: 0
FCF margin (%): 9.014026180401194
Revenue growth (%): -37.713760743950466
Rule of 40 score: -28.69973456354927
Financial ratios for JRS — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 240925203
Buffett classification: The Gruesome
Stock price: 7.13
Shares outstanding: 28892471
Market cap (USD): 206003318.23
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KEL.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.7952755905511815
Shares outstanding: 202198000
Market cap (USD): 767397133.8582678
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KEL.TO — annual report dated 2022-12-31
Total revenue: 450998529.4117647
Gross profit: 226914705.88235292
Operating income: 179327941.17647058
Net income: 116733823.52941176
Capital expenditures: 233485294.11764705
Operating cash flow: 225016176.4705882
Depreciation & amortization: 85428676.47058822
Net tangible assets: 662811764.7058823
Owner earnings: -31322794.11764705
Return on net tangible assets (%): -4.725745043398001
Capex to operating income (%): 130.20017549182816
Buffett classification: The Gruesome
Stock price: 3.6838235294117645
P/E ratio: 6.380856271809924
Shares outstanding: 202198000
Book value: 662811764.7058823
P/B ratio: 1.1237907799215465
Market cap (USD): 744861750
Debt to equity: 0.013698326203872983
Current ratio: 1.2764034144220429
Quick ratio: 1.2764034144220429
Effective tax rate (%): 24.472523656154404
Interest coverage ratio: 167.04520547945205
COGS to revenue (%): 49.68615392641818
SG&A to revenue (%): 2.8231473299443395
Free cash flow (dilution-adjusted): -13656617.647058822
Buyback yield (%): 0
Retained earnings: -180710294.11764705
Receivables turnover: 7.724328136412866
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.434578316726082
FCF margin (%): -3.0280847400702364
Rule of 40 score: -3.0280847400702364
Financial ratios for KEL.TO — annual report dated 2023-12-31
Total revenue: 375439393.93939394
Gross profit: 139856060.6060606
Operating income: 93381060.6060606
Net income: 65131818.18181818
Capital expenditures: 214125757.57575756
Operating cash flow: 214563636.36363634
Depreciation & amortization: 95312878.78787878
Net tangible assets: 760350757.5757575
Owner earnings: -53681060.606060594
Return on net tangible assets (%): -7.060039076861456
Capex to operating income (%): 229.3031972286899
Buffett classification: The Gruesome
Stock price: 4.333333333333333
P/E ratio: 13.452585200176797
Shares outstanding: 202198000
Book value: 760350757.5757575
P/B ratio: 1.152351496468436
Market cap (USD): 876191333.3333333
Debt to equity: 0.0014516824870499361
Current ratio: 0.8345809449699149
Quick ratio: 0.8345809449699149
Effective tax rate (%): 24.898451217275085
Interest coverage ratio: 94.09389312977098
COGS to revenue (%): 62.74869849469308
SG&A to revenue (%): 3.681746640300254
Free cash flow (dilution-adjusted): -5556060.6060606055
Buyback yield (%): 0
Retained earnings: -121054545.45454545
Receivables turnover: 9.424002129803945
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.543851380307617
FCF margin (%): -1.479882158279188
Revenue growth (%): -16.75374320420117
Rule of 40 score: -18.23362536248036
Financial ratios for KEL.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.637037037037037
Shares outstanding: 202198000
Market cap (USD): 937599614.8148148
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KEL.TO — annual report dated 2024-12-31
Total revenue: 327574825.1748252
Gross profit: 94042657.34265734
Operating income: 47162237.762237765
Net income: 31764335.664335664
Capital expenditures: 232969930.06993008
Operating cash flow: 146255244.75524476
Depreciation & amortization: 98946853.14685315
Net tangible assets: 743359440.5594406
Owner earnings: -102258741.25874126
Return on net tangible assets (%): -13.756298188906154
Capex to operating income (%): 493.97556418848785
Buffett classification: The Gruesome
Stock price: 4.909090909090909
P/E ratio: 31.249146027342977
Shares outstanding: 202198000
Book value: 743359440.5594406
P/B ratio: 1.3353006761968909
Market cap (USD): 992608363.6363636
Debt to equity: 0.10448408472592764
Current ratio: 0.7615110142512233
Quick ratio: 0.7615110142512233
Effective tax rate (%): 28.078092342770283
Interest coverage ratio: 18.356559608056614
COGS to revenue (%): 71.29124397991598
SG&A to revenue (%): 4.5082317177306415
Free cash flow (dilution-adjusted): -92900699.3006993
Buyback yield (%): 0
Retained earnings: -79978321.67832167
Receivables turnover: 7.950035640338074
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.969666333351264
FCF margin (%): -28.36014618984185
Revenue growth (%): -12.748946843946637
Rule of 40 score: -41.10909303378848
Financial ratios for KEL.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.909090909090909
Shares outstanding: 202198000
Market cap (USD): 992608363.6363636
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KEL.TO — quarterly report dated 2025-03-31
Total revenue: 99651048.95104896
Gross profit: 32333566.433566436
Operating income: 18919580.41958042
Net income: 13272027.972027972
Capital expenditures: 73248951.04895106
Operating cash flow: 60789510.48951049
Depreciation & amortization: 30607692.307692308
Net tangible assets: 759625174.8251748
Owner earnings: -29369230.769230783
Return on net tangible assets (%): -3.866279283857333
Capex to operating income (%): 387.15948992792465
Buffett classification: The Gruesome
Stock price: 4.755244755244755
P/E ratio: 18.11141788292323
Shares outstanding: 202198000
Book value: 759625174.8251748
P/B ratio: 1.2657571271808694
Market cap (USD): 961500979.0209789
Debt to equity: 0.09658885869365091
Current ratio: 0.5339999845682584
Quick ratio: 0.5339999845682584
Effective tax rate (%): 24.59973779349251
Interest coverage ratio: 13.413485374318293
COGS to revenue (%): 67.5532101529112
SG&A to revenue (%): 4.035059403091909
Free cash flow (dilution-adjusted): -13961538.461538464
Buyback yield (%): 0
Retained earnings: -66706293.70629371
Receivables turnover: 2.3335189218399464
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9560437812556706
FCF margin (%): -14.010427996996514
Rule of 40 score: -14.010427996996514
Financial ratios for KEL.TO — quarterly report dated 2025-06-30
Total revenue: 84976642.33576642
Gross profit: 21920437.956204377
Operating income: 9102919.708029196
Net income: 23694160.583941605
Capital expenditures: 66388321.16788321
Operating cash flow: 44303649.63503649
Depreciation & amortization: 31699270.072992697
Net tangible assets: 818743795.6204379
Owner earnings: -10994890.510948904
Return on net tangible assets (%): -1.3428975669509726
Capex to operating income (%): 729.30799454735
Buffett classification: The Gruesome
Stock price: 5.357664233576642
P/E ratio: 29.305401368618757
Shares outstanding: 202198000
Book value: 818743795.6204379
P/B ratio: 1.3231355138145586
Market cap (USD): 1083308992.7007298
Debt to equity: 0.13662019169477185
Current ratio: 0.8571004224608343
Quick ratio: 0.8571004224608343
Effective tax rate (%): 24.243272888515484
Interest coverage ratio: 4.644692737430167
COGS to revenue (%): 74.20416086859419
SG&A to revenue (%): 4.619560549055988
Free cash flow (dilution-adjusted): -23249635.03649635
Buyback yield (%): 0
Retained earnings: -45933576.642335765
Receivables turnover: 2.469150989416531
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8473856477835542
FCF margin (%): -27.360030235874177
Revenue growth (%): -14.725792422406878
Rule of 40 score: -42.08582265828105